$1.2-Million Loss for Cortex Pharmaceuticals
- Share via
Irvine-based Cortex Pharmaceuticals Inc. posted a loss of $1.2 million, or 12 cents a share, for the fiscal first quarter ended Sept. 30, compared with a loss of $1.3 million, or 14 cents a share, for the same period a year ago. The company reported no revenue.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
